newsfilter
← Latest News
GlobeNewswire·

FibroBiologics Granted Extension by Nasdaq to Regain Compliance

HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the